Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,052.20
+8.50 (0.81%)
Apr 22, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 109.19 billion as of April 22, 2026. Its market cap has decreased by -37.90% in one year.
Market Cap
109.19B
Enterprise Value
105.88B
Revenue
11.59B
Ranking
n/a
PE Ratio
35.16
Stock Price
1,052.20
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 109.19B, an increase of 10.70%. That is a compound annual growth rate of 3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 110.08B | -21.80% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 585.04B |
| Anthem Biosciences | 414.36B |
| OneSource Specialty Pharma | 178.92B |
| Blue Jet Healthcare | 71.53B |
| Supriya Lifescience | 49.88B |
| Zota Health Care | 43.70B |
| Dishman Carbogen Amcis | 26.58B |
| Panacea Biotec | 20.71B |